Skip to main content

By Market & Region

Filter fairsonline.org news by target market and region. Use the dropdown above to focus on the markets most relevant to your business.

University of Phoenix Study on AI-Driven Science Education Wins Editor's Choice

Image
University of Phoenix Study on AI-Driven Science Education Wins Editor's Choice

Phoenix – September 26, 2026 -- A peer-reviewed study from University of Phoenix examining AI-supported storytelling in environmental science education has been named an Editor's Choice paper by the journal Glacies.

Study links AI-generated imagery to measurable gains in student engagement

The paper, "Harnessing AI, Virtual Landscapes, and Anthropomorphic Imaginaries to Enhance Environmental Science Education at Jökulsárlón Proglacial Lagoon, Iceland," was published in February 2026. It reports that 87.1% of surveyed students enjoyed the anthropomorphic narratives used in the course, while 82.0% agreed the approach reinforced systems thinking.

STEMREGEN Ranks No. 332 on Inc. 5000 With 1,017% Growth

Image
STEMREGEN Ranks No. 332 on Inc. 5000 With 1,017% Growth

Whitefish, Mont. – September 25, 2026 -- STEMREGEN, a maker of science-backed stem cell supplements, has landed at No. 332 on the 2026 Inc. 5000 list after posting 1,017% revenue growth over three years, far outpacing the list's 130% median.

Company secures third straight Inc. 5000 ranking as growth trajectory accelerates

STEMREGEN previously ranked No. 265 in 2025 and No. 1,765 in 2024, marking three consecutive years on the annual list of America's fastest-growing private companies. The 2026 ranking measures revenue growth from 2022 through 2025.

Los Angeles Orbit Unveils Brand, Signs Yaamava' as Founding Partner

Image
Los Angeles Orbit Unveils Brand, Signs Yaamava' as Founding Partner

Los Angeles – September 25, 2026 -- Los Angeles Orbit, the newest franchise in League One Volleyball (LOVB), unveiled its team name, logo and brand identity today at Intuit Dome ahead of its inaugural professional season.

Ohanian, Rae and James headline ownership group at Intuit Dome reveal

Team owners Alexis Ohanian, Issa Rae and Savannah James attended the unveiling alongside LOVB Commissioner Sandra Idehen and volleyball legend Misty May-Treanor. Players including Carli Lloyd, Kotoe Inoue, Annie Drews Schumacher, Madi Kingdon Rishel and Kathryn Boden joined the event, which also featured activist Malala Yousafzai.

MAYPHARM Launches HYALMASS AQUATOX, a Five-Active Aesthetic Formula

Image
MAYPHARM Launches HYALMASS AQUATOX, a Five-Active Aesthetic Formula

Seoul – September 26, 2026 -- MAYPHARM has announced the upcoming launch of HYALMASS AQUATOX, a new aesthetic formulation combining five high-interest active ingredients into a single product for the global cosmeceutical market.

MAYPHARM combines five actives into one formulation to meet multifunctional demand

The new product integrates PDRN, Exosomes, Botulinum Peptide, GHK-Cu, and Succinic Acid in one advanced skin solution. Botulinum Peptide is designed to support a smoother skin appearance, while GHK-Cu is studied for skin conditioning and regeneration. Succinic Acid is positioned for antioxidant activity, PDRN for skin regeneration and recovery, and Exosomes for advanced rejuvenation approaches.

Sunwest Bank Assumes $605M in Deposits in FDIC-Backed Nano Banc Deal

Image
Sunwest Bank Assumes $605M in Deposits in FDIC-Backed Nano Banc Deal

Irvine, Calif. – September 25, 2026 -- Sunwest Bank has acquired Nano Banc of Irvine, California, in an FDIC-assisted transaction that transfers approximately $605 million in deposits and $227 million in loans to the Sandy, Utah-based lender.

Regulators shut Nano Banc on September 25 before handing control to Sunwest

California's Department of Financial Protection and Innovation closed Nano Banc on Friday, September 25, placing it into FDIC receivership. The FDIC then entered an agreement with Sunwest Bank to acquire substantially all of Nano Banc's deposits and a portion of its assets, including the $605 million deposit book and $227 million loan portfolio.

MSE Gives MedStar Health $1.1M for D.C. Maternal, Pediatric Care

Image
MSE Gives MedStar Health $1.1M for D.C. Maternal, Pediatric Care

Washington, D.C. – September 25, 2026 -- Monumental Sports & Entertainment (MSE) has donated $1.1 million to MedStar Health, extending a five-year philanthropic commitment first pledged in 2024 to fund maternal, infant and pediatric care programs across Washington, D.C.

MSE and MedStar Health extend a five-year funding pledge into its third year

The gift continues annual support MSE committed in 2024 to expand access to specialized health services for birthing mothers and children in the District. Since 2019, MSE and The Leonsis Family have contributed more than $13 million to MedStar Health initiatives, including pediatric community health, COVID-19 response and sports medicine programs.

N95 Mask Market to Triple to $11.08B by 2034 on Safety Rules

Image
N95 Mask Market to Triple to $11.08B by 2034 on Safety Rules

Pune – – September 25, 2026 -- The global N95 mask market is projected to grow from $3.27 billion in 2025 to $11.08 billion by 2034, a 14.52% compound annual growth rate, according to Maximize Market Research.

North America dominates as major respirator makers expand capacity

North America held the largest regional share in 2025, driven by hospital demand, workplace safety mandates, and infection-control requirements. Manufacturers including 3M, Honeywell, Moldex-Metric, Cardinal Health, and Medline Industries maintain significant production presence in the region, supporting its lead position through continued investment in respiratory-protection capacity.

AI Clinical Trials Market to Hit $7.32B by 2034, 15.5% CAGR

Image
AI Clinical Trials Market to Hit $7.32B by 2034, 15.5% CAGR

Pune, India – September 25, 2026 -- The global AI in Clinical Trials Market is set to more than triple from USD 2 billion in 2025 to USD 7.32 billion by 2034, expanding at a 15.5% compound annual growth rate, according to Maximize Market Research.

Pharmaceutical firms accelerate AI adoption to cut trial delays

Pharmaceutical and biotechnology companies, along with contract research organizations, hospitals and research institutes, are deploying machine learning, natural language processing and deep learning to speed patient screening, cohort selection, trial design and large-scale data analysis. These tools are applied across Phase I, Phase II and Phase III trials for patient recruitment, safety monitoring, drug discovery and personalized medicine.

MagLev Aero Wins Dual DARPA Awards to Fast-Track Drone Propulsion

Image
MagLev Aero Wins Dual DARPA Awards to Fast-Track Drone Propulsion

Boston – – September 25, 2026 -- MagLev Aero has secured concurrent contracts from the Defense Advanced Research Projects Agency under its Minimum Viable Product (MVP) and Embedded Entrepreneur Initiative (EEI) programs, providing non-dilutive funding to push its propulsion platform to Technology Readiness Level 6 (TRL-6).

DARPA funding targets flight-tested production for defense drones

The MVP award funds a full-scale, flight-relevant propulsion demonstration culminating in a TRL-6 test in an operational environment, aimed at de-risking adoption for airframers and OEMs building autonomous drones and crewed aircraft.

Webco Industries Posts Record FY2026 Net Income of $18.3 Million

Sand Springs, Okla. – September 25, 2026 -- Webco Industries, Inc. (OTC: WEBC) reported fiscal 2026 net income of $18.3 million, or $26.50 per diluted share, nearly double the $9.3 million, or $12.30 per diluted share, earned in fiscal 2025.

Annual net sales climb 14.8 percent to $670.9 million on stronger margins

Full-year net sales reached $670.9 million, up from $584.7 million in fiscal 2025. Gross profit for the year rose to $94.0 million, or 14.0 percent of net sales, compared with $66.8 million, or 11.4 percent, a year earlier. Income from operations increased to $28.0 million after $20.0 million in depreciation, versus $16.6 million after $19.0 million in depreciation in fiscal 2025.

Sabre Financial Secures 90% Tender for Debt, Sets Redemption

Image
Sabre Financial Secures 90% Tender for Debt, Sets Redemption

Southlake, Texas – September 25, 2026 -- Sabre Corporation (Nasdaq: SABR) disclosed that its indirect subsidiary, Sabre Financial Borrower, LLC, has secured tenders exceeding 90% of the aggregate principal amount outstanding on its targeted securities as of the September 25, 2026 early tender deadline, clearing the threshold required to force redemption of the remaining debt.

Over 90% acceptance triggers mandatory redemption of holdout bonds

Because more than 90% of the outstanding principal was validly tendered under the terms of the Indenture, Sabre Financial intends to issue a notice of redemption covering any securities that remain outstanding after the early settlement. The redemption price will match the Total Consideration offered in the tender, plus accrued and unpaid interest, with the redemption date expected on October 13, 2026.

International Paper CEO to Present at Baird Conference Nov. 11

Image
International Paper CEO to Present at Baird Conference Nov. 11

Memphis – September 25, 2026 -- International Paper Chief Executive Officer Andy Silvernail will speak at the Baird 2026 Global Industrial Conference on November 11, 2026.

Fireside chat scheduled for 8:30 a.m. ET on November 11

The Fireside Chat and Q&A session is set to begin at 8:30 a.m. ET (7:30 a.m. CT), giving investors direct access to Silvernail's commentary on the corrugated packaging maker's strategy and market outlook.

Webcast access available via investor relations page

Interested parties can listen to the live webcast through International Paper's Investors tab on the company website, under the Events & Presentations section. A replay will be posted approximately three hours after the presentation concludes.

Clinical Trials Market to Hit $99.4B by 2034 on AI, Decentralized Trial Growth

Image
Clinical Trials Market to Hit $99.4B by 2034 on AI, Decentralized Trial Growth

Pune – September 25, 2026 -- The global clinical trials market reached USD 58.19 billion in 2025 and is forecast to grow at a 6.13% compound annual rate through 2034, reaching USD 99.4 billion, according to Maximize Market Research.

North America retains dominant share on trial infrastructure and R&D spend

North America leads global trial activity, underpinned by extensive pharmaceutical and biotechnology infrastructure, significant cancer research burden, and the presence of major contract research organizations. The United States drives the bulk of regional Phase I-IV trial volume, while Canada contributes through government investment in trial infrastructure. Europe holds a substantial share as well, with the UK, France, Germany, Italy, Spain, Sweden and Austria supporting research across oncology, cardiovascular disease, CNS conditions, diabetes, obesity and autoimmune disorders.

Dietary Supplements Market to Hit $324.88B by 2034, Says MMR

Image
Dietary Supplements Market to Hit $324.88B by 2034, Says MMR

Pune, India – September 25, 2026 -- The global dietary supplements market was valued at USD 186.36 billion in 2025 and is forecast to reach USD 324.88 billion by 2034, expanding at a compound annual growth rate of 6.37% between 2026 and 2034, according to a new report from Maximize Market Research.

North America dominates supplement demand on preventive healthcare spending

North America leads the global market, driven by high consumer spending on health and wellness, strong preventive healthcare awareness, and regulatory clarity that supports major dietary supplement manufacturers. The United States remains the largest contributor within the region, with strong uptake of vitamins, minerals, herbal supplements, probiotics, and sports nutrition products.

NeuroSense Cuts H1 Costs 28%, Targets Dec. 2026 Canada ALS Filing

Image
NeuroSense Cuts H1 Costs 28%, Targets Dec. 2026 Canada ALS Filing

Cambridge, Mass. – September 25, 2026 -- NeuroSense Therapeutics (NASDAQ: NRSN) cut operating expenses to $3.4 million in the first half of 2026, down from $4.7 million a year earlier, as the biotech pushes its ALS candidate PrimeC toward a Canadian regulatory filing targeted for December 2026.

NeuroSense trims R&D and G&A spending by double digits in H1 2026

Research and development expenses fell 16% to $2,102 thousand from $2,503 thousand, driven by lower subcontractor and consultant costs, partly offset by higher share-based payment expense. General and administrative expenses dropped 38.6% to $1,345 thousand from $2,189 thousand on reduced professional services spending.

Sun Life, KC Royals Hit $50,000 Goal for Youth Dental Access

Image
Sun Life, KC Royals Hit $50,000 Goal for Youth Dental Access

Kansas City, Mo. – September 25, 2026 -- Sun Life U.S. and the Kansas City Royals Foundation have completed the first "Every Single Smile" campaign, raising $50,000 to expand dental care access for underserved youth in Kansas City through nonprofit TeamSmile.

Every Royals single triggered a donation toward the season-long fundraising goal

The campaign converted a core baseball statistic into a philanthropic mechanism, with each single hit by the Royals generating a contribution from Sun Life and the Kansas City Royals Foundation over the course of the season.

Funds will finance a new December dental clinic and expand preventive care access

The $50,000 will support an additional TeamSmile dental clinic in Kansas City this December and strengthen the Dental Home Project, which links underserved youth with local dentists for ongoing preventive care relationships.

KLX Energy Tightens Q3 Guidance, Cites $125M Rights Offering Close

Houston – September 25, 2026 -- KLX Energy Services Holdings (Nasdaq: KLXE) has tightened its third-quarter 2026 revenue guidance to a range of $180 million to $185 million, implying a 9% sequential improvement over the second quarter.

Adjusted EBITDA margin set to expand roughly 200 basis points sequentially

The oilfield services provider now projects an Adjusted EBITDA margin of 13% to 14% for the quarter ending September 30, 2026, up from the prior quarter. At the midpoint of the new guidance range, Adjusted EBITDA is expected to rise approximately 30% sequentially.

Allstream Energy Partners Lands OEM SEO Deal in Gas Processing

Image
Allstream Energy Partners Lands OEM SEO Deal in Gas Processing

Houston – September 25, 2026 -- Allstream Energy Partners has secured a Search Engine Optimization agreement with a major oil and gas original equipment manufacturer specializing in gas processing for the midstream sector. The OEM's identity and the financial terms of the deal were not disclosed.

Allstream Energy Partners to build technical content spanning traditional and AI-driven search

Under the agreement, Allstream will develop technical content for the OEM while supporting its search visibility through Answer Engine Optimization (AEO) and Generative Engine Optimization (GEO). The scope targets both conventional search engines and AI-powered discovery platforms increasingly used by technical buyers evaluating midstream equipment.

abrdn Global Infrastructure Income Fund Sets Oct. 30 Distribution Date

Image
abrdn Global Infrastructure Income Fund Sets Oct. 30 Distribution Date

Philadelphia – September 25, 2026 -- The abrdn Global Infrastructure Income Fund (NYSE: ASGI) will pay its next shareholder distribution on October 30, 2026, to investors of record as of October 6, 2026, with the ex-dividend date also set for October 6, 2026.

Fund confirms managed distribution policy tied to SEC exemptive order

ASGI operates under a distribution policy designed to deliver stable payouts sourced from current income, supplemented as needed by realized capital gains and return of capital, under an exemptive order granted by the U.S. Securities and Exchange Commission. The structure allows the closed-end fund to distribute long-term capital gains more frequently than standard limits set under Section 19(b) of the Investment Company Act of 1940 and Rule 19b-1.

Saber Healthcare Discloses Ransomware Attack Exposing Patient Data

Beachwood, Ohio – September 25, 2026 -- Saber Healthcare Group has disclosed a cybersecurity incident in which an outside party encrypted a portion of its corporate network files on July 27, 2026, potentially exposing personal and medical information tied to an undisclosed number of individuals.

Attacker encrypted files causing service outage on July 27, 2026

Saber detected a service outage affecting internal and external computer systems on that date. The company secured and isolated its systems and launched an investigation with outside cybersecurity experts, who confirmed an unauthorized party had accessed the corporate network and encrypted a small portion of files, triggering the outage.